Preferred Label : Farber lipogranulomatosis;
Symbol : FRBRL;
CISMeF acronym : FRBRL;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Ac deficiency; Ceramidase deficiency; Acid ceramidase deficiency; N-laurylsphingosine deacylase deficiency; Farber disease;
Description : Farber lipogranulomatosis is an autosomal recessive lysosomal storage disorder characterized
by early-onset subcutaneous nodules, painful and progressively deformed joints, and
hoarseness by laryngeal involvement. Based on the age of onset, the severity of symptoms,
and the difference in organs affected, 6 clinical subtypes due to deficiency of acid
ceramidase have been distinguished. The most severe form is subtype 4, a rare neonatal
form of the disease with death occurring before 1 year of age (summary by Alves et
al., 2013).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the N-acylsphingosine amidohydrolase 1 gene (ASAH1, 613468.0001);
Laboratory abnormalities : Histiocytic infiltration of liver, spleen, and lungs; Ceramidase deficiency; Elevated urine ceramide levels;
Prefixed ID : #228000;
Origin ID : 228000;
UMLS CUI : C0268255;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)